Routine use of glycoprotein IIb/IIIa inhibitor therapy is associated with an improved in-hospital outcome after percutaneous coronary intervention: Insights from a large, prospective, single-centre registry.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples